Mzumara, Grace
Chirombo, James
Swarthout, Todd D.
Bar-Zeev, Naor
Harawa, Philliness Prisca
Jalloh, Mohamed Sanusi
Kirolos, Amir
Mukhula, Victoria
Newberry, Laura
Ogunlade, Olawale
Wachepa, Richard
French, Neil
Heyderman, Robert S.
Iroh Tam, Pui-Ying
Funding for this research was provided by:
Wellcome Trust (WT091909/B/10/Z, WT091909/B/10/Z)
Bill and Melinda Gates Foundation (OPP1117653)
National Institute for Health and Care Research (16/136/46)
Article History
Received: 6 May 2024
Accepted: 12 September 2024
First Online: 5 October 2024
Change Date: 21 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s41479-025-00161-3
Declarations
:
: This work was funded by the Bill & Melinda Gates Foundation (OPP1117653 to RSH), a Wellcome Programme Grant (WT091909/B/10/Z to RSH), and National Institute for Health & Care Research (NIHR) Global Health Research Unit on Mucosal Pathogens using UK aid from the UK Government (16/136/46 to RSH), Wellcome Trust Programme Grant (WT091909/B/10/Z) to NF, RSH; an investigator initiated grant by GlaxoSmithKline Biologicals to NBZ, NF, and National Institute for Health Research. NBZ and NF received an investigator-initiated grant by GlaxoSmithKline Biologicals to support data collection. Malawi-Liverpool-Wellcome Programme is supported by a Strategic Award from Wellcome, UK (206545/Z/17/Z). PI received grant funding from Bill & Melinda Gates Foundation. For the remaining authors no competing interests were declared.